Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
ambrosia hispida/hypersensitivity
Link salvestatakse lõikelauale
Leht 1 alates 31 tulemused
HAL-MRE1 Subcutaneous Immunotherapy in Ragweed Allergic Patients First-in-human
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A chemically modified, aluminum hydroxide adsorbed ragweed extract (HAL-MRE1) for subcutaneous administration was developed for the treatment of ragweed pollen-induced allergic rhinitis/rhinoconjunctivitis (ARC) with or without asthma. The aim of this first-in-human phase I study is to assess the
Desensitization and Cross-Desensitization During Oral Grass or Ragweed Pollen Immunotherapy
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
To induce clinical tolerance, a failure to respond to an allergen to which one was previously responsive, is an important objective for physicians, one that plays a significant role in the primary prevention of allergic reactions in the clinical practice of Allergy & Immunology. The tolerance
Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
ToleroMune Ragweed Follow up Study
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Subjects who were randomised in study TR002 and who completed all dosing visits and the PTC will be invited to attend the Screening Visit for TR002B. Subjects will attend the EEC for 4 visits on successive days. Following the final EEC visit a follow-up visit will be performed 3-10 days later.
Allergenic Effect of Ambrosia in Israel
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Identification of Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed Allergy
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Safety and Tolerability Study of Ragweed SLIT Tablets
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
ToleroMune Ragweed Exposure Chamber Study
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This study is designed as a randomised, double-blind, placebo-controlled, parallel group study to evaluate the safety and tolerability of ToleroMune Ragweed in ragweed allergic subjects with allergic rhinoconjunctivitis,subjects may also have controlled asthma. The efficacy of ToleroMune Ragweed
A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Subjects who had a positive skin test to ragweed within 24 months of Visit 1 were instructed to complete a diary, which assessed their allergic signs and symptoms 3 times a day for 4 weeks. During the in-office visits, subjects were asked to completed a quality of life questionnaire, as well as a
Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081)
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
